Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects

被引:54
|
作者
Ramirez, L [1 ]
Braverman, LE [1 ]
White, B [1 ]
Emerson, CH [1 ]
机构
[1] UNIV MASSACHUSETTS, SCH MED, DEPT MED, DIV ENDOCRINOL & METAB, WORCESTER, MA 01655 USA
来源
关键词
D O I
10.1210/jc.82.9.2836
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recombinant human TSH (rhTSH) is known to stimulate I-131 uptake and thyroglobulin (Tg) release from the postoperative remnant and metastases in thyroid cancer patients, but its effects on serum thyroid hormone and Tg concentrations in normal subjects have not been reported. Before using rhTSH in the management of thyroid disorders other than cancer, the thyroid response to rhTSH in normal subjects must be assessed. Six subjects, two men and four women, without evidence of thyroid disease, including normal serum free T-4 index and TSH concentrations and negative tests for antithyroid peroxidase and Tg, were studied. Each received 0.1 mg rhTSH, im, 11% of the lowest dose that has been administered to thyroid cancer patients. Blood was obtained before; 2, 4, and 8 h after; and 1, 2, 3, 4, 7, and about 3 weeks after rhTSH administration. Serum TSH significantly increased at 2 h (mean +/- se, 2.4 +/- 0.9 to 40.7 +/- 7.4 mU/mL), peaked at 4 h (50.9 +/- 9.3), remained significantly elevated for 1 day, and was significantly below baseline (0.8 +/- 0.5) 7 days after rhTSH administration. Serum T-3 increased significantly at 4 h (115 +/- 4 to 190 +/- 14 ng/dL), peaked at 24 h (217 +/- 23 ng/dL), and remained significantly elevated for 3 days (151 +/- 12 ng/dL). Serum T-4 increased significantly at 8 h (7.3 +/- 0.2 to 9.8 +/- 0.4 mu g/dL), peaked at 24 h (11.2 +/- 0.5 mu g/dL), and remained significantly elevated for 4 days (9.4 +/- 0.5 mu g/dL). Serum Tg did not change for the first 8 h, increased significantly at 1 day (15.9 +/- 3.9 to 34.7 +/- 6.0 ng/mL), peaked at 2 days (44.2 +/- 7.0 ng/mL), and remained significantly elevated for 4 days (37.7 +/- 13.7 ng/mL). All values returned to baseline at 3 weeks. TSH antibodies were not detected at 3 weeks. A single dose of 0.1 mg rhTSH is a potent stimulator of thyroid function in normal subjects. rhTSH may be a useful agent to test thyroid reserve and for use in clinical settings that require direct thyroid stimulation.
引用
收藏
页码:2836 / 2839
页数:4
相关论文
共 50 条
  • [1] The effects of recombinant human thyrotropin, in normal subjects and patients with goitre
    Nielsen, VE
    Bonnema, SJ
    Hegedüs, L
    [J]. CLINICAL ENDOCRINOLOGY, 2004, 61 (06) : 655 - 663
  • [2] Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects
    Torres, MST
    Ramirez, L
    Simkin, PH
    Braverman, LE
    Emerson, CH
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04): : 1660 - 1664
  • [3] The effect of recombinant human thyrotropin (rhTSH) on thyroid function in mice and rats
    Colzani, RM
    Alex, S
    Fang, SL
    Braverman, LE
    Emerson, CH
    [J]. THYROID, 1998, 8 (09) : 797 - 801
  • [4] Effects of 0.9 mg recombinant human thyrotropin on thyroid size and function in normal subjects:: A randomized, double-blind, cross-over trial
    Nielsen, VE
    Bonnema, SJ
    Hegedüs, L
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05): : 2242 - 2247
  • [5] Recombinant human thyrotropin in the management of thyroid cancer
    McDougall, IR
    Weigel, RJ
    [J]. CURRENT OPINION IN ONCOLOGY, 2001, 13 (01) : 39 - 43
  • [6] Recombinant human thyrotropin and thyroid cancer management
    Robbins, RJ
    Robbins, AK
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (05): : 1933 - 1938
  • [7] Recombinant human thyrotropin in the management of thyroid disorders
    Paz-Filho, Gilberto J.
    Graf, Hans
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (11) : 1721 - 1732
  • [8] Tear thyrotropin receptor stimulator in normal smokers and thyroid eye disease patients
    Baker, GRC
    Gullu, S
    Mazzi, B
    Ragapaksa, S
    Mazziotti, G
    Ludgate, M
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U609 - U609
  • [9] DIFFERENCES BETWEEN THYROID STIMULATOR IN HYDATIDIFORM MOLE AND HUMAN CHORIONIC THYROTROPIN
    HERSHMAN, JM
    HIGGINS, HP
    STARNES, WR
    [J]. METABOLISM, 1970, 19 (10): : 735 - &
  • [10] THYROTROPIN IS A POTENT GROWTH-FACTOR FOR NORMAL HUMAN THYROID-CELLS IN PRIMARY CULTURE
    ROGER, PP
    DUMONT, JE
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 149 (02) : 707 - 711